FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndFCF margin (%) YoY (%)
Mar 31, 202511-45.98%
Mar 31, 202420.3-235.33%
Mar 31, 2023-15-170.96%
Mar 31, 202221.2+11.69%
Mar 31, 202119-548.35%
Mar 31, 2020-4.2-199.52%
Mar 31, 20194.2-59.58%
Mar 31, 201810.5-323.77%
Mar 31, 2017-4.7+767.32%
Mar 31, 2016-0.5-104.14%
Mar 31, 201513.1
AI Chat